Aggregatibacter actinomycetemcomitans induces Th17 cells in atherosclerotic lesions

Pathogens and Disease

Volumn 73, Issue 3, 2015, Pages

  Jia, Ru ^a,b   Hashizume Takizawa, Tomomi ^a   Du, Yuan ^a,c   Yamamoto, Masafumi ^a   Kurita Ochiai, Tomoko ^a  

^a NIHON UNIVERSITY   (Japan)

^b TONGJI UNIVERSITY   (China)

^c TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Aggregatibacter actinomycetemcomitans; Atherosclerosis; Inflammasome; MicroRNA; Th17 cells

Indexed keywords

CD4 ANTIGEN; CRYOPYRIN; INFLAMMASOME; INTERLEUKIN 17; INTERLEUKIN 17 RECEPTOR; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 6; MICRORNA; MICRORNA 146B; MICRORNA 155; PROTEIN; PROTEIN AIM 2; PROTEIN IL17RA; PROTEIN MINCLE; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RETINOID RELATED ORPHAN RECEPTOR GAMMA T; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; CYTOKINE;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; AORTA SINUS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL POPULATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SPLEEN; TH17 CELL; TROPISM; ANIMAL; ATHEROSCLEROSIS; BIOSYNTHESIS; BLOOD; GENE EXPRESSION PROFILING; IMMUNOLOGY; MICROBIOLOGY; PATHOLOGY;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMALS; ATHEROSCLEROSIS; CYTOKINES; FEMALE; GENE EXPRESSION PROFILING; MICE; SPLEEN; TH17 CELLS;

EID: 84938115243     PISSN: None     EISSN: 2049632X     Source Type: Journal    
DOI: 10.1093/femspd/ftu027     Document Type: Article

References (40)

1. Adibrad M, Deyhimi P, Ganjalikhani Hakemi M, et al. Signs of the presence of Th17 cells in chronic periodontal disease. J Periodontal Res 2012;47:525-31.
2. Ather JL, Ckless K, Martin R, et al. Serum amyloid A activates the NLRP3 inflammasome and promotes Th17 allergic asthma in mice. J Immunol 2011;187:64-73.
3. Belibasakis GN, Johansson A. Aggregatibacter actinomycetemcomitans targets NLRP3 and NLRP6 inflammasome expression in human mononuclear leukocytes. Cytokine 2012;59:124-30.
4. Bostanci N, Emingil G, Saygan B, et al. Expression and regulation of the NALP3 inflammasome complex in periodontal diseases. Clin Exp Immunol 2009;157:415-22.
5. Chen C, Wang T, Chen W. Occurrence of Aggregatibacter actinomycetemcomitans serotypes in subgingival plaque from United States subjects. Mol Oral Microbiol 2010;25:207-14.
6. Cheng X, Yu X, Ding YJ, et al. The Th17/Treg imbalance in patients with acute coronary syndrome. Clin Immunol 2008;127:89-97.
7. Cortelli JR, Aquino DR, Cortelli SC, et al. Aggregatibacter actinomycetemcomitans serotypes infections and periodontal conditions: a two-way assessment. Eur J Clin Microbiol 2012;31:1311-8.
8. Desel C, Werninghaus K, Ritter M, et al. The Mincle-activating adjuvant TDB induces MyD88-dependent Th1 and Th17 responses through IL-1R signaling. PLoS One 2013;8:e53531.
9. Diaz-Zuniga J, Yanez JP, Alvarez C, et al. Serotype-dependent response of human dendritic cells stimulated with Aggregatibacter actinomycetemcomitans. J Clin Periodontol 2014;41:242-51.
10. Dong C. Diversification of T-helper-cell lineages: finding the family root of IL-17-producing cells. Nat Rev Immunol 2006;6:329-33.
11. Du F, Yu F, Wang Y, et al. MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscl Throm Vas 2014;34:759-67.
12. Eid RE, Rao DA, Zhou J, et al. Interleukin-17 and interferongamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells. Circulation 2009;119:1424-32.
13. Figuero E, Sanchez-Beltran M, Cuesta-Frechoso S, et al. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol 2011;82:1469-77.
14. Gao Q, Jiang Y, Ma T, et al. A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice. J Immunol 2010;185:5820-7.
15. George J, Schwartzenberg S, Medvedovsky D, et al. Regulatory T cells and IL-10 levels are reduced in patients with vulnerable coronary plaques. Atherosclerosis 2012;222:519-23.
16. Jia R, Kurita-Ochiai T, Oguchi S, et al. Periodontal pathogen accelerates lipid peroxidation and atherosclerosis. J Dent Res 2013;92:247-52.
17. Kirii H, Niwa T, Yamada Y, et al. Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice. Arterioscl Throm Vas 2003;23:656-60.
18. Kozarov EV, Dorn BR, Shelburne CE, et al. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscl Throm Vas 2005;25:e17-8.
19. Liu YL, Wu W, Xue Y, et al. MicroRNA-21 and-146b are involved in the pathogenesis of murine viral myocarditis by regulating TH-17 differentiation. Arch Virol 2013;158: 1953-63.
20. Liu Z, Lu F, Pan H, et al. Correlation of peripheral Th17 cells and Th17-associated cytokines to the severity of carotid artery plaque and its clinical implication. Atherosclerosis 2012;221:232-41.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001;25:402-8.
22. McGeachy MJ, McSorley SJ. Microbial-induced Th17: superhero or supervillain? J Immunol 2012;189:3285-91.
23. Maddur MS, Miossec P, Kaveri SV, et al. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol 2012;181:8-18.
24. Matsushima Y, Sakurai T, Ohoka A, et al. Four strains of spontaneously hyperlipidemic (SHL) mice: phenotypic distinctions determined by genetic backgrounds. J Atheroscler Thromb 2001;8:71-9.
25. Menu P, Vince JE. The NLRP3 inflammasome in health and disease: the good, the bad and the ugly. Clin Exp Immunol 2011;166:1-15.
26. Mills KH, Dungan LS, Jones SA, et al. The role of inflammasomederived IL-1 in driving IL-17 responses. J Leukocyte Biol2013;93:489-97.
27. Moutsopoulos NM, Kling HM, Angelov N, et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. J Autoimmun 2012;39:294-303.
28. O'Connor W, Jr, Zenewicz LA, Flavell RA. The dual nature of T(H)17 cells: shifting the focus to function. Nat Immunol 2010;11:471-6.
29. Ouyang W, Kolls JK, Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008;28:454-67.
30. Strowig T, Henao-Mejia J, Elinav E, et al. Inflammasomes in health and disease. Nature 2012;481:278-86.
31. Taleb S, Romain M, Ramkhelawon B, et al. Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis. J Exp Med 2009;206:2067-77.
32. Veldhoen M, Hocking RJ, Atkins CJ, et al. TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006;24:179-89.
33. Viladomiu M, Hontecillas R, Pedragosa M, et al. Modeling the role of peroxisome proliferator-activated receptor gamma and microRNA-146 inmucosal immune responses to Clostridium difficile. PLoS One 2012;7:e47525.
34. Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007;25:821-52.
35. Wen H, Ting JP, O'Neill LA. A role for the NLRP3 inflammasome in metabolic diseases-did Warburg miss inflammation? Nat Immunol 2012;13:352-7.
36. Young JL, Libby P, Schonbeck U. Cytokines in the pathogenesis of atherosclerosis. Thromb Haemostasis 2002;88:554-67.
37. Zhang J, Cheng Y, Cui W, et al. MicroRNA-155 modulates Th1 and Th17 cell differentiation and is associated withmultiple sclerosis and experimental autoimmune encephalomyelitis. J Neuroimmunol 2014;266:56-63.
38. Zhang T, Kurita-Ochiai T, Hashizume T, et al., Aggregatibacter actinomycetemcomitans accelerates atherosclerosis with an increase in atherogenic factors in spontaneously hyperlipidemic mice. FEMS Immunol Med Mic 2010;59: 143-51.
39. Zhou X, Nicoletti A, Elhage R, et al. Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice. Circulation 2000;102:2919-22.
40. Zhou X, Robertson AK, Rudling M, et al. Lesion development and response to immunization reveal a complex role for CD4 in atherosclerosis. Circ Res 2005;96:427-34.